Funder
National Natural Science Foundation of China
Guangzhou Health Care and Cooperative Innovation Major Project
Pearl River S&T Nova Program of Guangzhou
grant from the CAS Youth Innovation Promotion Association
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Drug Discovery,Molecular Medicine
Reference49 articles.
1. Olin JT, Wechsler ME (2014) Asthma: pathogenesis and novel drugs for treatment. BMJ 349(nov24 8):g5517
2. Chung KF (2013) New treatments for severe treatment-resistant asthma: targeting the right patient. Lancet Respir Med 1(8):639–652
3. Nixon J, Newbold P, Mustelin T, Anderson GP, Kolbeck R (2017) Monoclonal antibody therapy for the treatment of asthma and chronic obstructive pulmonary disease with eosinophilic inflammation. Pharmacol Ther 169:57–77
4. Yalcin AD, Bisgin A, Cetinkaya R, Yildirim M, Gorczynski RM (2013) Clinical course and side effects of anti-IgE monoclonal antibody in patients with severe persistent asthma. Clin Lab 59(1-2):71–77
5. Pelaia G, Vatrella A, Maselli R (2012) The potential of biologics for the treatment of asthma. Nat Rev Drug Discov 11(12):958–972
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献